Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2C | P28335 | 3/20 | 0.44 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.39 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.39 |
| ▸ | HTR2A | P28223 | 1/20 | 0.37 |
| ▸ | HTR2B | P41595 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.37 |
| ▸ | CASP1 | P29466 | 2/20 | 0.36 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.36 |
| ▸ | KDM1A | O60341 | 1/20 | 0.35 |
| ▸ | PLA2G7 | Q13093 | 1/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | PROKR1 | Q8TCW9 | 2/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL31406372 | 0.83 | ALDH1A1 (0.45) | HTR2CCHRNB2CHRNA4ALDH1A1CASP1 | |
| SCHEMBL18031194 | 0.77 | ALDH1A1 (0.50) | HTR2CCHRNB2CHRNA4ALDH1A1CASP1 | |
| SCHEMBL1515219 | 0.77 | HTR2C (0.67) | HTR2CHTR2AHTR2BTSHR | |
| SCHEMBL2916099 | 0.76 | CHRNB2 (0.63) | CHRNB2CHRNA4ALDH1A1CASP1CYP3A4 | |
| SCHEMBL21568469 | 0.75 | HTR2C (0.50) | HTR2CHTR2AHTR2BALDH1A1KDM1A | |
| SCHEMBL31469392 | 0.73 | HTR2C (0.67) | HTR2CHTR2AHTR2BTSHR | |
| SCHEMBL43079 | 0.73 | HTR2C (0.67) | HTR2CHTR2AHTR2BTSHR | |
| SCHEMBL29871435 | 0.72 | HTR2C (0.64) | HTR2CHTR2AHTR2BTSHR | |
| SCHEMBL8130416 | 0.72 | HTR2C (0.64) | HTR2CHTR2AHTR2BTSHR | |
| SCHEMBL1128179 | 0.72 | HTR2C (0.64) | HTR2CHTR2AHTR2BTSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230337534-A1 | NITROGEN-CONTAINING COMPOUND, AND ORGANIC ELECTROLUMINESCENT DEVICE AND ELECTRONIC APPARATUS THEREOF | SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) | 2023-10-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230337534-A1 | NITROGEN-CONTAINING COMPOUND, AND ORGANIC ELECTROLUMINESCENT DEVICE AND ELECTRONIC APPARATUS THEREOF | NUDC, SLC29A2, SLC6A19 | HTR2C 3937/4885CHRNB2 2105/4885CHRNA4 1840/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.